Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 3/20 | 0.49 |
| ▸ | LATS1 | O95835 | 6/20 | 0.40 |
| ▸ | LATS2 | Q9NRM7 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17563611 | 0.93 | KMT2A (0.46) | GSK3BCYP3A4CYP2C9KDM4EMEN1 | |
| SCHEMBL21347891 | 0.84 | ABCG2 (0.44) | GSK3BLATS1LATS2NPC1MEN1 | |
| SCHEMBL1102447 | 0.83 | ADORA2A (0.53) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL26496047 | 0.80 | MEN1 (0.53) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL12786337 | 0.80 | MAPT (0.50) | GSK3BNPC1CYP3A4CYP2C9KDM4E | |
| SCHEMBL24589786 | 0.76 | MAPT (0.52) | GSK3BNPC1KDM4EMEN1ALDH1A1 | |
| SCHEMBL17694986 | 0.76 | MAPT (0.52) | GSK3BNPC1KDM4EMEN1ALDH1A1 | |
| SCHEMBL17694987 | 0.76 | MAPT (0.52) | GSK3BNPC1KDM4EMEN1ALDH1A1 | |
| SCHEMBL13086515 | 0.76 | NPC1 (0.47) | GSK3BLATS1LATS2NPC1ALDH1A1 | |
| SCHEMBL11996110 | 0.75 | GSK3B (0.53) | GSK3BLATS1LATS2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-04-22 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | OCIAD1, OR10J3, ORMDL3 | GSK3B 3771/4885LATS1 1293/4885LATS2 1014/4885 |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | GSK3B 4033/4885LATS1 807/4885LATS2 759/4885 |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | GSK3B 3423/4885LATS1 1784/4885LATS2 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.